Genomma Lab Internacional, S.A.B. de C.V. (FRA:GEKA)
Germany · Delayed Price · Currency is EUR 0.8000
0.00 (0.00%)
Last updated: Jan 28, 2026, 8:07 AM CET
Genomma Lab Internacional Cash Flow Statement
Financials in millions MXN. Fiscal year is January - December.
Millions MXN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 1,715 | 2,091 | 1,085 | 1,366 | 1,308 | 1,404 |
Depreciation & Amortization | 405.53 | 359.59 | 227.3 | 227.13 | 170.27 | 158.99 |
Other Amortization | 11.98 | 11.98 | 15.52 | 8.05 | 12.12 | 16.36 |
Loss (Gain) From Sale of Assets | -24.03 | - | - | - | - | - |
Asset Writedown & Restructuring Costs | 67.08 | 34.22 | 26.95 | 24.01 | 9.78 | 1.05 |
Loss (Gain) on Equity Investments | 597.99 | 597.99 | 58.6 | -22.75 | 90.38 | 0.61 |
Stock-Based Compensation | 0.21 | - | - | - | - | - |
Other Operating Activities | 231.82 | 408.2 | 308.06 | 725.41 | 689.34 | 568.19 |
Change in Accounts Receivable | -481.13 | -461.59 | 100.11 | -206.05 | -245.28 | -755.64 |
Change in Inventory | -167.05 | -242.7 | -164.18 | -434.59 | -227.6 | -227.55 |
Change in Accounts Payable | 6.09 | -112.54 | 280.29 | 453.63 | -171.81 | -211.88 |
Change in Other Net Operating Assets | -220.03 | 347.48 | 309.45 | -86.5 | -166.71 | 760.9 |
Operating Cash Flow | 2,084 | 3,034 | 2,247 | 2,055 | 1,468 | 1,715 |
Operating Cash Flow Growth | -18.88% | 35.01% | 9.35% | 39.94% | -14.36% | 70.27% |
Capital Expenditures | -490.83 | -270.81 | -238.44 | -402.96 | -630.21 | -696.85 |
Sale of Property, Plant & Equipment | 12.34 | 15.42 | 13.11 | 22 | 5.9 | 9.03 |
Sale (Purchase) of Intangibles | -42.41 | -675.03 | -88.9 | -19.47 | -206.58 | -7.78 |
Investment in Securities | 92.41 | 92.41 | -144.9 | -205.93 | - | - |
Other Investing Activities | 23.93 | 106.04 | 156.91 | 118.14 | 65.27 | 31.95 |
Investing Cash Flow | -404.57 | -731.97 | -302.21 | -488.22 | -765.62 | -663.65 |
Long-Term Debt Issued | - | 4,276 | 5,494 | 4,315 | 2,054 | 4,832 |
Long-Term Debt Repaid | - | -4,241 | -5,616 | -3,867 | -2,634 | -4,474 |
Net Debt Issued (Repaid) | 758.29 | 34.89 | -122.28 | 448.13 | -579.9 | 358.08 |
Issuance of Common Stock | 1,674 | 1,674 | 1,742 | 460.27 | 76.9 | 283.34 |
Repurchase of Common Stock | -1,711 | -1,663 | -1,904 | -994.92 | -155.81 | -15.44 |
Common Dividends Paid | -769.57 | -778.82 | -580.7 | -777.66 | -391.76 | - |
Other Financing Activities | -853.42 | -858.22 | -811.57 | -498.2 | -418.68 | -436.12 |
Financing Cash Flow | -902.22 | -1,591 | -1,677 | -1,362 | -1,469 | 189.85 |
Foreign Exchange Rate Adjustments | -169.83 | 90.82 | -77.59 | -171.06 | -72.54 | -59.79 |
Net Cash Flow | 606.91 | 801.53 | 190.39 | 33.11 | -839.04 | 1,181 |
Free Cash Flow | 1,593 | 2,763 | 2,009 | 1,652 | 838.14 | 1,018 |
Free Cash Flow Growth | -33.66% | 37.56% | 21.60% | 97.08% | -17.64% | 532.15% |
Free Cash Flow Margin | 8.76% | 14.85% | 12.20% | 9.82% | 5.41% | 7.34% |
Free Cash Flow Per Share | 1.59 | 2.82 | 2.10 | 1.66 | 0.83 | 1.01 |
Cash Interest Paid | 826.52 | 858.22 | 811.57 | 509.09 | 418.68 | 436.12 |
Cash Income Tax Paid | 834.51 | 808.79 | 981.14 | 706.13 | 838.05 | 751.54 |
Levered Free Cash Flow | 735.56 | 1,220 | 2,387 | 1,829 | 525.7 | 339.74 |
Unlevered Free Cash Flow | 1,262 | 1,763 | 2,890 | 2,149 | 791.33 | 611.57 |
Change in Working Capital | -862.11 | -469.36 | 525.67 | -273.51 | -811.4 | -434.17 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.